6J98
| |
7YSI
| Crystal structure of thioredoxin 2 | 分子名称: | Thiol disulfide reductase thioredoxin, ZINC ION | 著者 | Chang, Y.J, Park, H.H. | 登録日 | 2022-08-12 | 公開日 | 2023-03-15 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.202 Å) | 主引用文献 | Comparison of the structure and activity of thioredoxin 2 and thioredoxin 1 from Acinetobacter baumannii. Iucrj, 10, 2023
|
|
7XAO
| |
1WKQ
| |
4UIP
| The complex structure of extracellular domain of EGFR with Repebody (rAC1). | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, EPIDERMAL GROWTH FACTOR RECEPTOR, ... | 著者 | Kang, Y.J, Cha, Y.J, Cho, H.S, Lee, J.J, Kim, H.S. | 登録日 | 2015-03-31 | 公開日 | 2015-11-25 | 最終更新日 | 2024-01-10 | 実験手法 | X-RAY DIFFRACTION (2.95 Å) | 主引用文献 | Enzymatic Prenylation and Oxime Ligation for the Synthesis of Stable and Homogeneous Protein-Drug Conjugates for Targeted Therapy. Angew.Chem.Int.Ed.Engl., 54, 2015
|
|
7EOY
| Engineered Hepatitis B virus core antigen T=3 | 分子名称: | Capsid protein,Immunoglobulin G-binding protein A | 著者 | Jeong, H, Heo, Y, Yoo, Y, Ryu, B, Yun, J, Cho, H, Lee, W. | 登録日 | 2021-04-24 | 公開日 | 2021-09-01 | 最終更新日 | 2022-02-16 | 実験手法 | ELECTRON MICROSCOPY (3.6 Å) | 主引用文献 | Structural and Functional Characterizations of Cancer Targeting Nanoparticles Based on Hepatitis B Virus Capsid. Int J Mol Sci, 22, 2021
|
|
7FDJ
| Engineered Hepatitis B virus core antigen with short linker T=4 | 分子名称: | Capsid protein,Immunoglobulin G-binding protein A | 著者 | Jeong, H, Heo, Y, Yoo, Y, Ryu, B, Yun, J, Cho, H, Lee, W. | 登録日 | 2021-07-16 | 公開日 | 2021-09-01 | 最終更新日 | 2024-06-12 | 実験手法 | ELECTRON MICROSCOPY (4.4 Å) | 主引用文献 | Structural and Functional Characterizations of Cancer Targeting Nanoparticles Based on Hepatitis B Virus Capsid. Int J Mol Sci, 22, 2021
|
|
7EP6
| Engineered Hepatitis B virus core antigen T=4 | 分子名称: | Capsid protein,Immunoglobulin G-binding protein A | 著者 | Jeong, H, Heo, Y, Yoo, Y, Ryu, B, Yun, J, Cho, H, Lee, W. | 登録日 | 2021-04-26 | 公開日 | 2021-09-01 | 最終更新日 | 2022-02-16 | 実験手法 | ELECTRON MICROSCOPY (3.86 Å) | 主引用文献 | Structural and Functional Characterizations of Cancer Targeting Nanoparticles Based on Hepatitis B Virus Capsid. Int J Mol Sci, 22, 2021
|
|
4CQG
| The crystal structure of MPK38 in complex with OTSSP167, an orally- administrative MELK selective inhibitor | 分子名称: | 1-[6-(3,5-dichloro-4-hydroxyphenyl)-4-({trans-4-[(dimethylamino)methyl]cyclohexyl}amino)-1,5-naphthyridin-3-yl]ethanone, Maternal embryonic leucine zipper kinase, SULFATE ION | 著者 | Cho, Y.S, Kang, Y.J, Cho, H.S. | 登録日 | 2014-02-17 | 公開日 | 2014-07-09 | 最終更新日 | 2023-12-20 | 実験手法 | X-RAY DIFFRACTION (2.57 Å) | 主引用文献 | The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor. Biochem.Biophys.Res.Commun., 447, 2014
|
|
2GQG
| X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain | 分子名称: | GLYCEROL, N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE, Proto-oncogene tyrosine-protein kinase ABL1 | 著者 | Klei, H.E. | 登録日 | 2006-04-20 | 公開日 | 2006-11-21 | 最終更新日 | 2017-10-18 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | The Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domain Elucidates Its Inhibitory Activity against Imatinib-Resistant ABL Mutants CANCER RES., 66, 2006
|
|